静脉曲张属支同期与分期治疗作为腔内消融辅助的系统综述与荟萃分析
OBJECTIVE: This review compares the outcomes of both concomitant and staged superficial varicose tributary (SVT) interventions as an adjunct to endovenous truncal ablation.…
要点
- 同期处理属支可显著降低再干预率,但随机试验亚组未见差异。
- 同期与分期在并发症和深静脉血栓风险上无显著差异。
- 同期组早期疾病严重度和生活质量改善更明显。
核心结论
- 同期和分期治疗均安全有效,同期组早期疾病严重度和生活质量改善更优。
- 荟萃分析提示同期干预再干预率显著更低,但研究存在偏倚且随机试验亚组未证实。
研究设计与样本
- 使用Downs and Black工具评估方法学质量,采用随机效应模型合并数据。
临床怎么用
- 对于接受腔内主干消融的静脉曲张患者,同期处理属支可能减少再干预并改善早期生活质量。
- 需权衡同期干预的潜在获益与研究偏倚,尤其随机试验未显示再干预差异。
局限性
- 纳入研究存在一定偏倚,再干预率的荟萃分析异质性高(I2=90%)。
- 随机试验亚组分析未发现再干预率差异,提示获益可能受混杂因素影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This review compares the outcomes of both concomitant and staged superficial varicose tributary (SVT) interventions as an adjunct to endovenous truncal ablation. METHODS: A systematic search of Medline through Pubmed, Embase, and the Cochrane Central Register of Controlled Trials was last performed in November 2019. All studies comparing the outcomes of both concomitant and staged treatments for SVT as an adjunct to endovenous truncal ablation were included. Each included study was subject to an evaluation of methodological quality using the Downs and Black assessment tool. Outcomes assessed included rates of re-intervention, complications, and thrombotic events. Quality of life (QOL) and disease severity were also analysed. Data were pooled with a random effects model. RESULTS: Fifteen studies (6 915 limbs) were included for analysis. Included studies were of reasonable methodological quality. Re-intervention rates were significantly lower in the concomitant group (6.3% vs. 36.1%) when compared with staged intervention (relative risk [RR] 0.21 [95% CI 0.07-0.62], p = .004, I2 = 90%, p ≤ .001). Reported complications (RR 1.14 [95% CI 0.67-1.93], p = .64) and rates of deep venous thrombosis (RR 1.41 [95% CI 0.72-2.77] p = .31) were similar in each group. Overall disease severity (Venous Clinical Severity Score) was lower in the concomitant group (-1.16 [95% CI, -1.97- -0.35] p = .005), while QOL, assessed using the Aberdeen Varicose Vein Questionnaire, favoured concomitant treatment when measured at less than three months (weighted mean difference [WMD] -3.6 [95% CI, -7.17- -0.03] p = .050) and between three and 12 months (WMD -1.61 [95% CI, -2.99- -0.23] p = .020). CONCLUSION: Concomitant and staged treatments are safe and effective. Improvements in early disease severity and QOL scores were better in the concomitant group. While meta-analysis suggests that concomitant intervention offers significantly lower rates of re-intervention, studies assessing its merits are subject to some biases. This benefit was not reflected by the randomised trial subgroup analysis, which identified no difference in re-intervention.
引用
- Aherne TM, Ryan ÉJ, Boland MR, et al. Concomitant vs. Staged Treatment of Varicose Tributaries as an Adjunct to Endovenous Ablation: A Systematic Review and Meta-Analysis. Eur J Vasc Endovasc Surg. 2020. PMID: 32771286. doi:10.1016/j.ejvs.2020.05.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。